Dark Forest Capital Management’s Adaptive Biotechnologies ADPT Stock Holding History

Dark Forest Capital Management’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-86,886	Closed	-$1.41M	–	771
2025 Q4	$1.41M	Sell	86,886 -14,509	-14%	-$237K	0.06%	527
2025 Q3	$1.52M	Sell	101,395 -82,573	-45%	-$1.01M	0.06%	577
2025 Q2	$2.14M	Buy	183,968 +29,387	+19%	+$267K	0.09%	415
2025 Q1	$1.15M	Buy	154,581 +102,887	+199%	+$791K	0.05%	617
2024 Q4	$310K	Buy	+51,694	New	+$285K	0.05%	651
2023 Q4	–	Sell	-46,031	Closed	-$251K	–	444
2023 Q3	$251K	Buy	+46,031	New	+$304K	0.02%	960
2022 Q4	–	Sell	-3	Closed	–	–	1110
2022 Q3	$0	Buy	+3	New	+$28	﹤0.01%	1097
2022 Q1	–	Sell	-182	Closed	-$5K	–	1224
2021 Q4	$5K	Sell	182 -6,136	-97%	-$188K	﹤0.01%	1133
2021 Q3	$215K	Buy	6,318 +2,629	+71%	+$95.1K	0.08%	221
2021 Q2	$151K	Buy	+3,689	New	+$143K	0.07%	227

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Dark Forest Capital Management's ADPT Position: Q1 2026 in Review

Dark Forest Capital Management sold out of Adaptive Biotechnologies (ADPT) in Q1 2026, closing a stake of 86,886 shares — an estimated $1.41M sold.

Dark Forest Capital Management first reported a position in ADPT in Q2 2021 and held it in 10 quarters. The position peaked at $2.14M in Q2 2025. 298 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.

Dark Forest Capital Management reported no remaining Adaptive Biotechnologies position as of Q1 2026 after selling out during the quarter.
Dark Forest Capital Management sold 86,886 Adaptive Biotechnologies shares in Q1 2026, an estimated $1.41M.
Dark Forest Capital Management first reported a position in Adaptive Biotechnologies in Q2 2021 and held it in 10 quarters.
Dark Forest Capital Management's Adaptive Biotechnologies position peaked at $2.14M in Q2 2025.
298 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.

Based on Dark Forest Capital Management's 13F filing for Q1 2026, filed 15 May 2026.